home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

2nd Annual Precision Medicine Congress

 
  January 29, 2018  
     
 
Oxford Global Conferences, Munich, Germany
2018-06-11


Join Oxford Global for the 2nd Annual Precision Medicine Congress, 11-12 June 2018, Munich as our panel of over 40 world class speakers discuss the latest regulatory updates, biomarker developments, information technologies and companion diagnostics for personalized therapies.         

View Agenda: http://bit.ly/2BF20WZ

Across two days, our event will bring together over 200 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of precision medicine. Over 40 presentations and case studies focusing on the key developments in precision medicine regulation, biomarkers, clinical development, digital technologies and diagnostics.

4 interactive streams:

  • Precision Medicine, Regulation, Reimbursement and Targeted Therapy
  • Precision Medicine, Biomarkers and Clinical Development
  • Precision Medicine: Genomics, Data analysis and Big Data Management
  • Precision Medicine and Diagnostics Development

2018 Live Webinar:

Precision Medicine & Cancer Genomics – Clinical And Pharmaceutical Applications
Hosted by Dr Honey Reddi, The Jackson Laboratory and Dr Michael Menden, AstraZeneca.
Register for Free Now:
http://bit.ly/2F8bytZ

2017 Free Webinar Recording:

Clinical Utility of Genomic Testing 
Hosted by Elaine Lyon, Professor, University of Utah & Medical Director of Molecular Genetics, ARUP Laboratories.
Download for Free:
http://bit.ly/2B3TOOO

For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.

 
 
Organized by: OxfordGlobal
Invited Speakers:

Chris Fearne, Deputy Prime Minister
Government of Malta

Patrick Mallon, Chief Executive Officer
Studio Biotherapeutics

Philip Arlen, President and Chief Executive Officer
Precision Biologics

Maurice Treacy, Co-Founder
Genomics Medicine Ireland

Sean Ennis, Co-Founder and Chief Scientific Officer
Genomics Medicine Ireland

Kári Stefánsson, Chief Executive Officer
deCODE Genetics

Rangaprasad Sarangarajan, Senior Vice President
BERG Health

Bruce Roberts, Chief Scientific Officer
Vedanta Biosciences

Fabien Gaire, Global Head of Pathology & Tissue Analytics
F. Hoffmann-La Roche

Akihiko Koyama, Senior Director, Head of Integrated Biology Engine
Eisai

Jane Wilkinson, Senior Director, Genomics Platform Project & Alliance Management
The Broad Institute

Bob Holt, Director, Biomarkers & Companion Diagnostics
BerGenBio

Baohong Zhang, Director of Clinical Biomarkers
Pfizer

Thomas Hach, Director, Healthcare Systems
Novartis

Cecilia Lindskog Bergström, Director, Tissue Atlas
Uppsala University

Hans Lehrach, Director
The Max Planck Institute of Molecular Genetics

Honey Reddi, Clinical Laboratory Director
The Jackson Laboratory

Jürgen Scheuenpflug, Global Head Clinical Biomarkers and Companion Diagnostics
Merck KGaA

Claudia Dollins, Head, Global Regulatory Affairs Biomarkers & Companion Diagnostics
Merck KGaA

Anna Bauer-Mehren, Head of Data Science
F. Hoffmann-La Roche

Matthias Ocker, Head of Biomarker Oncology
Bayer

Oliver Chao, Head, Emerging Biomedical Sciences Strategy and Innovation
Sanofi

Paolo Piraino, Head of Genomics and Biomarker Statistics
Bayer

Bruno Gomes, Head of Biomarkers, Oncology and Translational Area
F. Hoffmann-La Roche

Charles Cox, Head of Pharmacogenetics
GlaxosmithKline

Christophe Le Tourneau, Head of Phase I Programme & Co-head of the Clinical Trial Unit
Institut Curie

Marta Alarcón-Riquelme, Head, Area of Medical Genomics
GENYO

Ron van Schaik, Professor of Pharmacogenetics
Erasmus University Medical Centre

François-Pierre Martin, Senior Project Leader and Senior PI, Nutrition and Metabolic Health
Nestlé Institute of Health Sciences

Jürgen Eils, Group Leader
German Cancer Research Centre

Ana Alfirevic, Reader in Pharmacology
University of Liverpool

John Martignetti, Associate Professor
Icahn School of Medicine at Mount Sinai

Mathias Droescher, Senior Scientist
Abbvie

Michael Menden, Senior Scientist
Astrazeneca

Adam Sardar, Senior Computational Biologist
Merck KGaA

Melissa Konopko, Technical Program Manager
Merck KGaA

 

 
Deadline for Abstracts: N/A
 
Registration:

http://bit.ly/2BF20WZ

E-mail: g.alonso@oxfordglobal.co.uk
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.